The fate of soluble steroids within breast prostheses in humans.

Annals of plastic surgery 1990 Vol.24(5) p. 427-30

Morykwas MJ, Argenta LC, Oneal RM, Kaiser DG

관련 도메인

Abstract

The long-term fate of 6-alpha-methyl-methylprednisolone hemisuccinate (MPHS) placed into breast prostheses prior to implantation in humans was determined. MPHS hydrolyzes to the active form 6-alpha-methylprednisolone (MP) in water, which then diffuses out of the implant. Twenty prostheses were recovered 5.3 to 34.7 months after placement, and the solution inside was analyzed for MPHS and MP. Half-lives were calculated for the hydrolysis of MPHS to MP (3.4 +/- 0.58 months [mean +/- SEM]) and for the diffusion of MP out of the prostheses (20.63 +/- 6.10 months). The large half-lives found imply that MPHS slowly hydrolyzes to MP, and that active steroid is released for a longer time than was previously thought. This long release could be the cause of the long-term effects seen with steroids used in this manner.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 2
약물 steroids C0038317
Steroids
scispacy 1
약물 hemisuccinate scispacy 1
약물 6-alpha-methylprednisolone C0025815
methylprednisolone
scispacy 1
약물 steroid C0038317
Steroids
scispacy 1
질환 breast prostheses scispacy 1
질환 MPHS → 6-alpha-methyl-methylprednisolone hemisuccinate scispacy 1
기타 humans scispacy 1

MeSH Terms

Breast; Diffusion; Female; Humans; Hydrolysis; Methylprednisolone; Methylprednisolone Hemisuccinate; Prostheses and Implants; Prosthesis Design; Surgery, Plastic; Wound Healing

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문